Press Releases

Rho Promotes Mark Ubert to CFO

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has promoted Mark Ubert, MBA, to the position of Chief Financial Officer (CFO). As CFO, Mark will provide financial and strategic leadership to the growing organization, exemplified in the role he played in Rho’s acquisition of European CRO Dokumeds. Mark brings more than 30 years of experience to the role of Chief Financial Officer. He joined Rho in March of 2020 as VP of Finance.

Dolomite Bio announce launch of cost-effective Bioinformatics service with brand new RNAdia kit for single cell research

Dolomite Bio has announced the launch of a Bioinformatics Service which can be purchased alongside the recently launched RNAdia kit for single-cell research.

Flourish Research Adds Great Lakes Clinical Trials and Clinical Site Partners to the Network, Tripling Revenue and Expanding Clinical Expertise in Six Months

Great Lakes Clinical Trials and Clinical Site Partners join Excel Medical Clinical Trials and platform site Clinical Trials of Texas at Flourish Research, expanding capabilities to 60 indications.

Improved Image Quality and Resolution for all ZEISS Laser Scanning Microscopes

ZEISS LSM Plus and ZEISS Airyscan Joint Deconvolution introduced

Creative Bioarray Provides Reliable and Consistent FBS Products to Faciliatate The Research of Cell Culture

Creative Bioarray Launches A Wide Range of FISH Services to Support Detecting RNA and DNA Sequences

Histobiolab Has Developed Professional Tissue Microarray to Meet Precise Research Needs

Creative Biogene Provides Reliable and High Quality Pseudovirus Services to Support The Studies of SARS-CoV-2

Qvirus Platform Designed Customized AAV Testing Services to Accelerate The Development of Viral Vaccine and Gene Therapy

Microbiosci Provides Comprehensive Service for Pichia Pastoris Fermentation to Process Development of Microbiological Research

CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Formulation Projects

Quantum Dots & Upconverting Nanoparticles Provided by Alfa Chemistry Can Improve Medical Technology and Energy Research

Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform

The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation.

Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service

The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment.

BioIVT Launches GMP Grade Human AB Serum to Facilitate the Development and Manufacturing of Cell and Gene Therapies

This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies.

WuXi STA Launches its First Parenteral Formulation Manufacturing Line

CD ComputaBio Unveils Ligand-based Pharmacophore Model Service for Drug Design and Screening

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of ligand-based pharmacophore model service for scientists to accelerate the drug candidate development process.

Creative Proteomics Lipidomics Launches Exosomes Lipidomics Service to Study the Biological Characteristics of Vesicles

Lipidomics, a division of Creative Proteomics, is committed to providing untargeted lipidomics services, targeted lipidomics services, metabolic flux analysis services, and lipidomics related services for research institutions, biotechnology and pharmaceutical companies. The company continues to accelerate lipidomics research to make contributions in the fields of biopharmaceuticals, population health, the food industry, etc. Creative Proteomics Lipidomics has recently announced the launch of Exosomes Lipidomics Service, which can help scientists understand vesicle biogenesis and function, identify lipid-based biomarkers and unravel their monitoring function in diseases.

GutFlora Omics Platform Launches Virome Sequencing Service to Investigate Gut Microbiota

Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis

Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced Disease Cytokine Assays to help researchers obtain higher quality scientific research data.